Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia

Jin‐Hua Liang(Broad Institute), Wei Xu(Jiangsu Province Hospital)

Oncotarget

November 2, 2015

10.18632/oncotarget.6281

Cited by 26

Related Papers

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer

|Cell Death and Disease|2014|84

JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells

|Cell Death and Disease|2014|59

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

|Cell & Bioscience|2015|50

miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation

|Oncotarget|2014|43